Table 4. Unadjusted and Adjusted Relative Hazards of Incident Diabetes During Follow-up From 1986 to 2016 Among Lactation Duration Categories.
Multivariate Models | Time-Dependent Lactation Duration Categories, Adjusted Relative Hazard (95% CI) | P Value for Trenda | |||
---|---|---|---|---|---|
None (n = 322) |
>0 to 6 mo (n = 418) | >6 to <12 mo (n = 268) | ≥12 mo (n = 230) | ||
Model 1 Unadjusted | 1 [Reference] | 0.60 (0.43-0.83) | 0.36 (0.23-0.57) | 0.29 (0.17-0.49) | <.001 |
Model 2 (model 1 plus adjustment for race time-dependent parity and GD status during follow-up) | 1 [Reference] | 0.74 (0.53-1.04) | 0.55 (0.34-0.87) | 0.45 (0.26-0.80) | .003 |
Model 3 (model 2 plus age, baseline covariates [body mass index,b waist circumference, and fasting glucosec], and familiy history of diabetes) | 1 [Reference] | 0.84 (0.60-1.20) | 0.56 (0.35-0.91) | 0.50 (0.27-0.90) | .006 |
Model 4 (model 3 plus time-dependent physical activity scored and Diet Quality scoree during follow-up) | 1 [Reference] | 0.81 (0.56-1.19) | 0.53 (0.31-0.88) | 0.53 (0.29-0.98) | .01 |
Model 5 (model 4 plus time-dependent weight changef during follow-up) | 1 [Reference] | 0.75 (0.51-1.09) | 0.52 (0.31-0.87) | 0.53 (0.29-0.98) | .01 |
Abbreviation: GD, gestational diabetes.
No evidence of effect modification by race, GD status, or parity groups.
Calculated as weight in kilograms divided by height in meters squared.
Fasting serum glucose at baseline (year 0); there was missing data for 5 participants, and 10 participants had fasting glucose from year 7 before diabetes onset (all values at year 7 <100 mg/dL).
Quartiles for time-dependent physical activity score for race-specific quartiles were evaluated as the average of scores from years 0, 7, and 20 (19 women were missing follow-up physical activity score).
Quartiles for the a priori Diet Quality score were evaluated as the average of scores from years 0, 7, and 20 (10 women were missing average Diet Quality score).
Time-dependent weight change equals weight change above the median vs at or below from baseline through the end of follow-up.